Annual long term debt:
$595.14M+$2.04M(+0.34%)Summary
- As of today (July 1, 2025), BMRN annual long term debt is $595.14 million, with the most recent change of +$2.04 million (+0.34%) on December 31, 2024.
- During the last 3 years, BMRN annual long term debt has fallen by -$483.94 million (-44.85%).
- BMRN annual long term debt is now -45.05% below its all-time high of $1.08 billion, reached on December 31, 2022.
Performance
BMRN Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$595.65M+$512.00K(+0.09%)Summary
- As of today (July 1, 2025), BMRN quarterly long term debt is $595.65 million, with the most recent change of +$512.00 thousand (+0.09%) on March 31, 2025.
- Over the past year, BMRN quarterly long term debt has increased by +$2.04 million (+0.34%).
- BMRN quarterly long term debt is now -48.92% below its all-time high of $1.17 billion, reached on September 30, 2017.
Performance
BMRN Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
BMRN Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.3% | +0.3% |
| 3 y3 years | -44.9% | -44.9% |
| 5 y5 years | +22.4% | +22.4% |
BMRN Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.0% | +0.3% | -45.1% | +0.5% |
| 5 y | 5-year | -45.0% | +22.4% | -45.1% | +0.5% |
| alltime | all time | -45.0% | >+9999.0% | -48.9% | >+9999.0% |
BMRN Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $595.65M(+0.1%) |
| Dec 2024 | $595.14M(+0.3%) | $595.14M(+0.1%) |
| Sep 2024 | - | $594.63M(+0.1%) |
| Jun 2024 | - | $594.12M(+0.1%) |
| Mar 2024 | - | $593.61M(+0.1%) |
| Dec 2023 | $593.10M(-45.2%) | $593.10M(+0.1%) |
| Sep 2023 | - | $592.59M(-45.4%) |
| Jun 2023 | - | $1.08B(+0.1%) |
| Mar 2023 | - | $1.08B(+0.1%) |
| Dec 2022 | $1.08B(+0.4%) | $1.08B(+0.1%) |
| Sep 2022 | - | $1.08B(+0.1%) |
| Jun 2022 | - | $1.08B(+0.1%) |
| Mar 2022 | - | $1.08B(+0.1%) |
| Dec 2021 | $1.08B(+0.4%) | $1.08B(+0.1%) |
| Sep 2021 | - | $1.08B(+0.1%) |
| Jun 2021 | - | $1.08B(+0.1%) |
| Mar 2021 | - | $1.08B(+0.1%) |
| Dec 2020 | $1.08B(+121.1%) | $1.08B(+0.1%) |
| Sep 2020 | - | $1.07B(+0.1%) |
| Jun 2020 | - | $1.07B(+120.5%) |
| Mar 2020 | - | $486.71M(+0.1%) |
| Dec 2019 | $486.24M(-41.4%) | $486.24M(-42.4%) |
| Sep 2019 | - | $843.62M(+0.5%) |
| Jun 2019 | - | $839.16M(+0.5%) |
| Mar 2019 | - | $834.77M(+0.5%) |
| Dec 2018 | $830.42M(+2.1%) | $830.42M(+0.5%) |
| Sep 2018 | - | $826.12M(+0.5%) |
| Jun 2018 | - | $821.87M(+0.5%) |
| Mar 2018 | - | $817.67M(+0.5%) |
| Dec 2017 | $813.52M(+23.1%) | $813.52M(-30.2%) |
| Sep 2017 | - | $1.17B(+72.4%) |
| Jun 2017 | - | $676.21M(+1.2%) |
| Mar 2017 | - | $668.44M(+1.2%) |
| Dec 2016 | $660.76M(-0.2%) | $660.76M(+1.2%) |
| Sep 2016 | - | $653.18M(+1.2%) |
| Jun 2016 | - | $645.68M(-3.3%) |
| Mar 2016 | - | $668.01M(+0.9%) |
| Dec 2015 | $662.29M(+3.0%) | $662.29M(-0.8%) |
| Sep 2015 | - | $667.79M(+1.0%) |
| Jun 2015 | - | $661.49M(+0.9%) |
| Mar 2015 | - | $655.49M(+2.0%) |
| Dec 2014 | $642.90M(-1.9%) | $642.90M(-2.1%) |
| Sep 2014 | - | $656.88M(+0.9%) |
| Jun 2014 | - | $650.87M(-1.6%) |
| Mar 2014 | - | $661.42M(+0.9%) |
| Dec 2013 | $655.57M(+101.8%) | $655.57M(+737.1%) |
| Sep 2013 | - | $78.31M(-28.7%) |
| Jun 2013 | - | $109.82M(-0.0%) |
| Mar 2013 | - | $109.85M(-66.2%) |
| Dec 2012 | $324.86M | $324.86M(-0.0%) |
| Sep 2012 | - | $324.86M(-0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $324.87M(-0.0%) |
| Mar 2012 | - | $324.87M(-6.7%) |
| Dec 2011 | $348.33M(-7.7%) | $348.33M(-0.0%) |
| Sep 2011 | - | $348.34M(-7.7%) |
| Jun 2011 | - | $377.52M(-0.0%) |
| Mar 2011 | - | $377.52M(0.0%) |
| Dec 2010 | $377.52M(-24.1%) | $377.52M(-29.2%) |
| Sep 2010 | - | $533.41M(+2.3%) |
| Jun 2010 | - | $521.24M(-0.7%) |
| Mar 2010 | - | $524.86M(+5.6%) |
| Dec 2009 | $497.08M(0.0%) | $497.08M(0.0%) |
| Sep 2009 | - | $497.08M(0.0%) |
| Jun 2009 | - | $497.08M(0.0%) |
| Mar 2009 | - | $497.08M(0.0%) |
| Dec 2008 | $497.08M(-0.1%) | $497.08M(-0.0%) |
| Sep 2008 | - | $497.24M(-0.0%) |
| Jun 2008 | - | $497.25M(-0.0%) |
| Mar 2008 | - | $497.30M(-0.0%) |
| Dec 2007 | $497.38M(+122.1%) | $497.38M(-11.9%) |
| Sep 2007 | - | $564.32M(-0.1%) |
| Jun 2007 | - | $564.71M(+134.9%) |
| Mar 2007 | - | $240.44M(+7.4%) |
| Dec 2006 | $223.94M(+5.2%) | $223.94M(-23.6%) |
| Sep 2006 | - | $293.08M(-20.2%) |
| Jun 2006 | - | $367.31M(-0.1%) |
| Mar 2006 | - | $367.84M(+72.8%) |
| Dec 2005 | $212.92M(-6.6%) | $212.92M(-0.7%) |
| Sep 2005 | - | $214.45M(-0.7%) |
| Jun 2005 | - | $215.97M(+49.4%) |
| Mar 2005 | - | $144.60M(-36.6%) |
| Dec 2004 | $228.04M(+82.4%) | $228.04M(+2.7%) |
| Sep 2004 | - | $222.06M(+72.4%) |
| Jun 2004 | - | $128.78M(+3.0%) |
| Mar 2004 | - | $125.00M(0.0%) |
| Dec 2003 | $125.00M(+3055.8%) | $125.00M(0.0%) |
| Sep 2003 | - | $125.00M(0.0%) |
| Jun 2003 | - | $125.00M(+4192.6%) |
| Sep 2002 | - | $2.91M(-16.9%) |
| Mar 2002 | - | $3.50M(-11.6%) |
| Dec 2001 | $3.96M(+6973.2%) | $3.96M(+2613.0%) |
| Sep 2001 | - | $146.00K(-26.3%) |
| Jun 2001 | - | $198.00K(+321.3%) |
| Mar 2001 | - | $47.00K(-16.1%) |
| Dec 2000 | $56.00K(-34.1%) | $56.00K(-11.1%) |
| Sep 2000 | - | $63.00K(-7.4%) |
| Jun 2000 | - | $68.00K(-11.7%) |
| Mar 2000 | - | $77.00K(-9.4%) |
| Dec 1999 | $85.00K(-15.0%) | $85.00K(-15.0%) |
| Sep 1999 | - | $100.00K(-99.6%) |
| Jun 1999 | - | $26.10M(>+9900.0%) |
| Mar 1999 | - | $100.00K |
| Dec 1998 | $100.00K | - |
FAQ
- What is BioMarin Pharmaceutical annual long term debt?
- What is the all time high annual long term debt for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual long term debt year-on-year change?
- What is BioMarin Pharmaceutical quarterly long term debt?
- What is the all time high quarterly long term debt for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly long term debt year-on-year change?
What is BioMarin Pharmaceutical annual long term debt?
The current annual long term debt of BMRN is $595.14M
What is the all time high annual long term debt for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual long term debt is $1.08B
What is BioMarin Pharmaceutical annual long term debt year-on-year change?
Over the past year, BMRN annual long term debt has changed by +$2.04M (+0.34%)
What is BioMarin Pharmaceutical quarterly long term debt?
The current quarterly long term debt of BMRN is $595.65M
What is the all time high quarterly long term debt for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly long term debt is $1.17B
What is BioMarin Pharmaceutical quarterly long term debt year-on-year change?
Over the past year, BMRN quarterly long term debt has changed by +$2.04M (+0.34%)